Table 3.
Clinical and metabolic characteristics of the subjects separate by sex
| Men | Women | |
|---|---|---|
| N | 30 | 37 |
| Race (white/black) | 27/3 | 27/10 |
| Age (years) | 58 ± 9 | 56 ± 8 |
| Weight (kg) | 104 ± 9 | 89 ± 8‡ |
| BMI (kg/m2) | 32.6 ± 2.2 | 33.6 ± 2.5 |
| Body fat (%)* | 30 ± 4 | 42 ± 3‡ |
| Ratio VAT/SAT | 1.09 ± 0.61 | 0.59 ± 0.28‡ |
| Fat cell size (μL) | 0.73 ± 0.20 | 0.95 ± 0.22‡ |
| Fat cell number/mg tissue | 3733 ± 1022 | 3460 ± 1085 |
| Fasting glucose (mg/dl) (mM) (SI units) |
128 ± 29 8 ± 1.7 |
128 ± 33 8 ± 2 |
| Fasting insulin (μU/mL) (pM) (SI units) |
10 ± 4 69 ± 28 |
13 ± 6† 90 ± 42† |
| HbA1c (%) | 6.2 ± 1.2 | 6.4 ± 1.2 |
| Clamp study (last 30 minutes) | ||
| Glucose concentration (mg/dl) (mM) (SI units) |
104 ± 6 6 ± 0.3 |
105 ± 6 6.2 ± 0.3 |
| Insulin concentration (μU/mL) (pM) (SI units) |
156 ± 38 1083 ± 264 |
178 ± 47† 1236 ± 326† |
| Glucose disposal (mg/min per kilogram FFM) | 5.8 ± 2.6 | 5.9 ± 2.7 |
VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; SI, systéme internationale; HbA1c, hemoglobin A1c; FFM, fat-free mass.
*
DXA was used to assess percent body fat; data are mean ± standard deviation.
†
p < 0.05.
‡
p < 0.001.